Skinvisible Announces Worldwide License Agreement with Quoin Pharmaceuticals in Conjunction with Mutual Termination of Merger Agreement

Author's Avatar
Oct 22, 2019
Article's Main Image

LAS VEGAS, NV / ACCESSWIRE / October 22, 2019 / Skinvisible, Inc. ("Skinvisible") (OTCQB:SKVI), is pleased to announce that in conjunction with the mutual cancellation of the pending merger agreement with Quoin Pharmaceuticals, Inc. ("Quoin"), the parties have agreed to a product specific Licensing Agreement.